BioSpace News Archive

Policy

FDA Action Alert: Biogen/Ionis, Cidara and Incyte

An advisory committee will meet March 22 to discuss the fate of Biogen and Ionis’ ALS hopeful tofersen. For that and more, see inside.

March 17, 2023
·
3 min read
·
Tristan Manalac
Drug Development

The Rise, Fall and Future of Novavax

On Feb. 28, Novavax issued a candid warning to investors: it may not be able to continue operations beyond February 2024. BioSpace takes a deep dive into the vaccine maker’s prospects.

March 17, 2023
·
5 min read
·
Heather McKenzie
Drug Development

Esperion-Daiichi Sankyo Partnership Saga Continues with Payment Spat

For Daiichi Sankyo, recent results from the Phase III CLEAR trial of Esperion Therapeutics’ Nexletol (bempedoic acid) were not convincing enough to trigger a milestone payment.

March 17, 2023
·
2 min read
·
Tristan Manalac
Drug Development

FDA Reverses Course; Will Hold Adcomm for Sarepta’s DMD Gene Therapy

The FDA will hold an advisory committee meeting for Sarepta’s investigational gene therapy for Duchenne muscular dystrophy ahead of its May 29, 2023 action date.

March 17, 2023
·
2 min read
·
Tristan Manalac
Business

Amgen Cuts 450 Jobs in Second Round of Layoffs This Year

Amgen is terminating 450 workers in hopes of weathering dropping drug prices and rising inflation. This is Amgen’s second round of job cuts this year.

March 17, 2023
·
2 min read
·
Tristan Manalac
Drug Development

Pfizer and Astellas Seek Expanded Label for Expensive Prostate Cancer Drug

Pfizer and Astellas announced positive topline Phase III results Thursday for Xtandi plus leuprolide in non-metastatic castration-sensitive prostate cancer.

March 17, 2023
·
2 min read
·
Kate Goodwin
SYMBYX announces promising Sydney Adventist Hospital clinical trial results for Parkinson’s using the SYMBYX Neuro - a new light therapy wellness helmet

SYMBYX today announced the results of a Sydney Adventist Hospital (commonly known as the San) triple-blinded, randomised controlled trial investigating the effects of a new red/infrared light therapy helmet on patients living with Parkinson’s Disease.

March 17, 2023
·
6 min read
Business

Zomedica Appoints New Chief Financial Officer

Zomedica Corp., a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced that it has appointed Peter L. Donato as its Chief Financial Officer, effective March 16, 2023.

March 17, 2023
·
7 min read
Business

NRx Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023

NRx Pharmaceuticals, Inc. today announced that it will release its fourth quarter and full year 2022 financial results after the market closes on Thursday, March 30, 2023, via press release.

March 17, 2023
·
1 min read
Business

Sisram Medical Ltd. to Announce Full Year 2022 Financial Results on March 21, 2023

Sisram Medical Ltd today announced that it expects to release its financial results for the full year, ended December 31, 2022 on Tuesday, March 21, 2023.

March 17, 2023
·
2 min read